User profiles for "author:Silvia de Sanjose"

Silvia de Sanjosé

Consultant Senior, NCI, ISGlobal
Verified email at isglobal.org
Cited by 81704

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

S De Sanjosé, M Diaz, X Castellsagué… - The Lancet infectious …, 2007 - thelancet.com
We set out to estimate the age and genotype-specific prevalence of cervical human
papillomavirus (HPV) DNA in women with normal cervical cytology worldwide by meta …

Chapter 1: Human papillomavirus and cervical cancer—burden and assessment of causality

FX Bosch, S De Sanjosé - JNCI monographs, 2003 - academic.oup.com
Cervical cancer remains the second most common cancer in women worldwide and the
most frequent in developing countries. Pre-neoplasic cervical lesions represent an …

Carcinogenic human papillomavirus infection

M Schiffman, J Doorbar, N Wentzensen… - Nature reviews Disease …, 2016 - nature.com
Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

[HTML][HTML] Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

XS Puente, M Pinyol, V Quesada, L Conde… - Nature, 2011 - nature.com
Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western
countries, is a heterogeneous disease with variable clinical presentation and evolution,. Two …

[HTML][HTML] Epidemiologic classification of human papillomavirus types associated with cervical cancer

N Muñoz, FX Bosch, S De Sanjosé… - New England journal …, 2003 - Mass Medical Soc
Background Infection with human papilloma virus (HPV) is the main cause of cervical
cancer, but the risk associated with the various HPV types has not been adequately …

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

S de Sanjose, WGV Quint, L Alemany… - The lancet …, 2010 - thelancet.com
Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in
invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We …

[HTML][HTML] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

M Arbyn, E Weiderpass, L Bruni… - The Lancet Global …, 2020 - thelancet.com
Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

[HTML][HTML] Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners

X Castellsagué, FX Bosch, N Muñoz… - New England journal …, 2002 - Mass Medical Soc
Background It is uncertain whether male circumcision reduces the risks of penile human
papillomavirus (HPV) infection in the man and of cervical cancer in his female partner …

Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings

L Bruni, M Diaz, M Castellsagué, E Ferrer… - Journal of Infectious …, 2010 - academic.oup.com
Background. Baseline information on human papillomavirus (HPV) prevalence and type
distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the …

Human papillomavirus types in 115,789 HPV‐positive women: a meta‐analysis from cervical infection to cancer

P Guan, R Howell‐Jones, N Li, L Bruni… - … journal of cancer, 2012 - Wiley Online Library
Genotyping may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐
positive women in cervical screening programs; however, prospective data comparing the …